echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Hypertension: the relationship between serum magnesium and the risk of hypertension and chronic kidney disease progression

    Hypertension: the relationship between serum magnesium and the risk of hypertension and chronic kidney disease progression

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Chronic kidney disease (CKD) is a well-known public health problem, affecting approximately 34 million adults in the United States, accounting for more than 14% of the US population
    .


    Studies have reported that magnesium ions are involved in the regulation of blood pressure (BP)


    Recently, the heart blood vessels authoritative magazine published a research article on Hypertension, the researchers analyzed data from 3866 participants from chronic renal insufficiency queue (CRIC Research) of
    .


    Linear regression assessed the association between serum magnesium and baseline systolic blood pressure (SBP) and diastolic blood pressure (DBP)


    Heart blood vessels

    The subjects' average serum magnesium level was 2.
    0mEq/L (±0.
    3mEq/L)
    .


    Higher magnesium levels are associated with lower SBP (-3.


    In the time-to-event analysis, a higher baseline serum magnesium was associated with a lower risk of hypertensive events defined by the CRIC (adjusted hazard ratio of 0.
    77 [95% CI 0.
    46-1.
    31/1mEq/L])
    .


    Higher magnesium levels are associated with a significantly lower risk of CKD progression (adjusted hazard ratio is 0.


    It can be seen that in CKD patients, higher serum magnesium is associated with lower SBP and DBP, and lower risk of hypertension and CKD progression
    .


    In CKD patients, whether magnesium supplementation can optimize blood pressure control and prevent disease progression deserves further research


    In CKD patients, higher serum magnesium is associated with lower SBP and DBP and lower risk of hypertension and CKD progression


    Original source:

    Simon Correa.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.